We are live on
!
Find out more
SCM
Silvant Capital Management Portfolio holdings
AUM
$2.89B
1-Year Est. Return
34.45%
This Fund
S&P 500
This Quarter
Est. Return
+5.21%
1 Year Est. Return
+34.45%
3 Year Est. Return
+148.47%
5 Year Est. Return
+205.7%
10 Year Est. Return
–
AUM
$2.28B
AUM Growth
+$25.9M
(+1.1%)
Cap. Flow
-$48.9M
Cap. Flow
% of AUM
-2.15%
Top 10 Holdings %
Top 10 Hldgs %
56.73%
Holding
317
New
10
Increased
21
Reduced
98
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$38M |
| 2 |
Mercado Libre
MELI
|
+$16.2M |
| 3 |
GE Aerospace
GE
|
+$12.8M |
| 4 |
GE Vernova
GEV
|
+$5.35M |
| 5 |
Ares Management
ARES
|
+$4.75M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$38.3M |
| 2 |
Boeing
BA
|
+$22.7M |
| 3 |
Lam Research
LRCX
|
+$9.55M |
| 4 |
Apple
AAPL
|
+$9.24M |
| 5 |
Fair Isaac
FICO
|
+$6.35M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 45.87% |
| 2 | Consumer Discretionary | 13.06% |
| 3 | Healthcare | 11.97% |
| 4 | Communication Services | 10.82% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Allstate
ALL
$67.6B
| $13K | ﹤0.01% |
68
| – | – |
|
302
Wynn Resorts
WYNN
$10.1B
| $11.2K | ﹤0.01% |
117
| – | – |
|
303
APA Corp
APA
$12.7B
| $5.58K | ﹤0.01% |
228
| – | – |
|
304
Baxter International
BAX
$14.7B
| – | – |
-294
| Closed | -$10.8K |
|
305
Advance Auto Parts
AAP
$3.55B
| – | – |
-335
| Closed | -$21.2K |
|
|
306
Edwards Lifesciences
EW
$51.6B
| – | – |
-414,654
| Closed | -$38.3M |
|
307
Intel
INTC
$509B
| – | – |
-9,404
| Closed | -$291K |
|
|
308
Lam Research
LRCX
$398B
| – | – |
-89,510
| Closed | -$9.55M |
|
309
Newell Brands
NWL
$2.61B
| – | – |
-3,018
| Closed | -$19.3K |
|
310
Organon & Co
OGN
$3.56B
| – | – |
-441
| Closed | -$9.13K |
|
311
Super Micro Computer
SMCI
$20.5B
| – | – |
-7,420
| Closed | -$608K |
|
312
VF Corp
VFC
$5.99B
| – | – |
-2,127
| Closed | -$28.7K |
|
313
Viatris
VTRS
$20.6B
| – | – |
-1,238
| Closed | -$13.2K |
|
314
West Pharmaceutical
WST
$24.5B
| – | – |
-10,893
| Closed | -$3.59M |
|
315
Zimmer Biomet
ZBH
$18.5B
| – | – |
-12,378
| Closed | -$1.35M |
|
316
Solventum
SOLV
$15.2B
| – | – |
-335
| Closed | -$17.7K |
|
|
WRK
317
DELISTED
WestRock Company
WRK
| – | – |
-1,102
| Closed | -$55.4K |
|
Similar funds
NRCM
BAM
PFM
DMIC
LIP
HCC
CCPM
SCM
Silvant Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Silvant Capital Management held 317 positions worth $2.28B, up 1.1% from $2.25B the previous quarter. Its ten largest holdings account for 57% of the portfolio.
Silvant Capital Management's Q3 2024 filing shows 10 new, 21 increased, 98 reduced and 14 closed positions. Its largest new stake was Ares Management: 32,755 shares worth $5.1M. The largest sale was Edwards Lifesciences, an estimated $38.3M.
By sector, the portfolio is most concentrated in Technology at 46% of assets, down from 47% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Silvant Capital Management's largest Q3 2024 buy was Ares Management: 32,755 shares worth $5.1M.
- Silvant Capital Management added most to Netflix in Q3 2024, an estimated $38M increase.
- Silvant Capital Management's biggest Q3 2024 reduction was Boeing, cutting an estimated $22.7M.
- Silvant Capital Management fully exited Edwards Lifesciences in Q3 2024, selling an estimated $38.3M.
- Silvant Capital Management's ten largest holdings make up 57% of its $2.28B portfolio in Q3 2024.
- Silvant Capital Management opened 10 new positions and closed 14 in Q3 2024.
- Silvant Capital Management's portfolio value rose 1.1% quarter-over-quarter to $2.28B.
Based on Silvant Capital Management's 13F filing for Q3 2024, filed 29 Oct 2024.